What is the recommended management for septic shock in a newborn?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Septic Shock in Newborns

Begin immediate resuscitation with high-flow oxygen, establish IV/IO access, and administer 20 mL/kg boluses of isotonic crystalloid (preferably balanced/buffered solutions) up to 60 mL/kg within the first 5 minutes while simultaneously starting broad-spectrum antibiotics. 1, 2

Initial Resuscitation (0-15 Minutes)

Immediate Actions

  • Recognize shock signs: decreased perfusion, altered mental status, cyanosis, respiratory distress syndrome
  • Airway and oxygen: Provide high-flow oxygen per Neonatal Resuscitation Program (NRP) guidelines 1
  • Vascular access: Establish IV or intraosseous (IO) access immediately

Fluid Resuscitation

  • Administer balanced/buffered crystalloids (preferred over 0.9% saline) in 20 mL/kg boluses 2
  • Push rapidly up to and over 60 mL/kg until perfusion improves 1
  • Stop if rales or hepatomegaly develop (suggests fluid overload)
  • Correct hypoglycemia and hypocalcemia during resuscitation 1

Antimicrobial Therapy

  • Start broad-spectrum antibiotics immediately within the first hour, ideally within minutes of recognition 2, 3
  • Do not delay for blood cultures if this would postpone antibiotic administration
  • Obtain blood cultures before antibiotics when feasible without causing delay 2

Fluid-Refractory Shock (15-60 Minutes)

Vasoactive Agents

If shock persists after 40-60 mL/kg fluid resuscitation, begin vasoactive infusions immediately 2:

  • First-line options (no single agent is definitively superior):

    • Epinephrine (preferred over dopamine) 2
    • Norepinephrine (preferred over dopamine) 2
    • Dopamine (up to 10 mcg/kg/min) - acceptable if epinephrine/norepinephrine unavailable 1, 2
  • Route: May administer through peripheral IV or IO if central access not immediately available 2

    • Do not delay vasoactive therapy waiting for central access

Hemodynamic Phenotype-Directed Therapy

  • Cold shock (poor perfusion, high systemic vascular resistance): Titrate central epinephrine 1
  • Warm shock (bounding pulses, flash capillary refill, wide pulse pressure): Titrate central norepinephrine 1
  • Caveat: Do not rely solely on clinical "warm" vs "cold" categorization; use advanced hemodynamic monitoring when available 2

Airway Management

  • Consider intubation if needed, using atropine/ketamine for induction 1
  • Avoid etomidate (associated with adrenal suppression) 2

Catecholamine-Resistant Shock (After 60 Minutes)

Hydrocortisone

Add hydrocortisone if the newborn has adrenal insufficiency 1:

  • Peak cortisol after ACTH <18 μg/dL, OR
  • Basal cortisol <18 μg/dL in appropriately volume-loaded patient requiring epinephrine

Advanced Monitoring

  • Target goals:
    • Normal mean arterial pressure (MAP) for age
    • Central venous oxygen saturation (ScvO₂) >70% 1, 2
    • Cardiac index 3.3-6.0 L/min/m² 1
    • Capillary refill ≤2 seconds 1
  • Monitor lactate trends to guide ongoing resuscitation 2

Escalation Options

  • Vasopressin, terlipressin, or angiotensin can be considered with adequate cardiac output monitoring 1
  • Consider pulmonary artery catheter, PICCO, or Doppler ultrasound to guide therapy 1

Refractory Shock

Rule Out Correctable Causes

Before escalating to ECMO, exclude and treat 1:

  • Pericardial effusion → pericardiocentesis
  • Pneumothorax → thoracentesis
  • Ongoing blood loss → transfusion/hemostasis
  • Hypoadrenalism → hydrocortisone
  • Hypothyroidism → triiodothyronine
  • Inborn errors of metabolism → glucose/insulin or ammonia scavengers
  • Duct-dependent congenital heart disease → prostaglandin E 1, 4
  • Patent ductus arteriosus → consider closure

ECMO Consideration

  • Indications: Refractory shock after maximal therapy or PaO₂ <40 mmHg 1
  • Survival rate: 80% for newborn sepsis 1
  • ECMO flows: Keep <110 mL/kg to avoid hemolysis 1
  • Normalize calcium in pump prime (300 mg CaCl₂ per unit packed RBCs) 1

Continuous Renal Replacement Therapy (CRRT)

  • Initiate if inadequate urine output with ≥10% fluid overload despite diuretics 1
  • Best performed on ECMO circuit in newborns 1

Critical Pitfalls to Avoid

  1. Do not delay vasoactive agents waiting for central access—use peripheral/IO routes 2
  2. Do not restrict fluids prematurely—newborns may require >60 mL/kg 1
  3. Do not use etomidate for intubation 2
  4. Do not use starches for resuscitation (strong recommendation against) 2
  5. Do not delay antibiotics beyond 1 hour of recognition 2, 3
  6. Do not miss duct-dependent cardiac lesions—have prostaglandin E available within 10 minutes 4

Evidence Quality Note

The 2020 Surviving Sepsis Campaign guidelines 2 represent the most recent comprehensive pediatric/neonatal sepsis recommendations, though most recommendations are based on low to very low quality evidence. The 2009 ACCM guidelines 1 provide more specific neonatal algorithms that remain clinically relevant. The newer 2026 guidelines 5, 6 emphasize similar principles with added focus on performance improvement programs and conservative oxygen strategies, though specific neonatal recommendations remain largely unchanged.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.